Secondary Logo

Journal Logo

Response to Cohen et al

Bell, Rae F.a; Kalso, Eija A.b

doi: 10.1097/PR9.0000000000000731
Correspondence
Open

aRegional Centre of Excellence in Palliative Care, Haukeland University Hospital, Bergen, Norway

bPerioperative, Intensive Care and Pain Medicine, Pain Clinic, Helsinki University Hospital, University of Helsinki Helsinki, Finland

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Received February 01, 2019

Accepted February 06, 2019

Online date: May/June, 2019

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

We thank Drs. Cohen, Schwenk, and Viscusi for their letter with information about the recently published guidelines on the use of ketamine for acute pain and chronic noncancer pain.1 We commend the American Society of Regional Anesthesia & Pain Medicine and the American Academy of Pain Medicine for this important initiative. We trust that the guidelines will be regularly updated, in accordance with best current evidence and clinical expertise.

Back to Top | Article Outline

Disclosures

The authors have no conflict of interest to declare.

Back to Top | Article Outline

Reference

[1]. Cohen SP, Schwenk ES, Viscusi ER. Ketamine for pain management: let's not neglect practical concerns. PAIN Reports 2019;4:e728.
© 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain.